Combined chemo-immunotherapy versus monoimmunotherapy in advanced high PD-L1 positive NSCLC. Real-world data analyzed with propensity scores technique from the German prospective multicentre registry study (CRISP) (AIO-TRK-0315)

15. Januar 2026

Metzenmacher, M. et al.

Annals of Oncology, Volume 36, Supplement 2, 2025, Page S1092, ISSN 0923-7534.